The non-invasive cancer diagnostics market is estimated >>

Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access
Roots Analysis is pleased to announce the publication of its recent study, titled, “Liquid Biopsy and Other Non-Invasive Cancer Diagnostics Market (3rd Edition), 2019-2030: Focus on Circulating Tumor Markers such as CTCs, ctDNA, cfDNA, Exosomes and Other Biomarkers.”
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of this approach over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:

A detailed review of the overall landscape of the non-invasive cancer diagnostics market.

An analysis of the various partnerships pertaining to non-invasive cancer diagnostics, which have been established between 2016 and 2019.

An analysis of the investments made in companies engaged in the development of non-invasive cancer diagnostics.

An analysis of the initiatives of big pharma players.

A detailed acquisition target analysis.

Elaborate profiles of the key players engaged in this domain.

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Type of Tumor Marker
ctDNA
cfDNA
CTCs
Exosomes
Others
Application
Diagnosis / Early Diagnosis
Patient Monitoring
Recurrence Monitoring
Target Cancer Indication
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Bladder Cancer
Melanoma
Gastric Cancer
Pancreatic Cancer
Ovarian Cancer
Others

End Users

Hospitals
Research Institutes
Others

Key Geographical Regions

Press Release: Variation 1 (Format 2)
North America
Europe

Asia-Pacific

Rest of the World


Key companies covered in the report:

Amoy Diagnostics

DiaCarta

HaploX Biotechnology

NeoGenomics

QIAGEN

Swift Biosciences

Sysmex Inostics

Thermo Fisher Scientific


For more information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html
Other recent offerings

Companion Diagnostics Market (2nd Edition), 2019-2030

Novel Technologies for Delivery of Proteins, Antibodies and Nucleic Acids, 2019-2030

Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

 [email protected]

You may also like

Discussion

No comments yet... Be the first to leave a reply! Login here

avatar
BenJ
0 Karma
747 Posts

Made with by Mamby